Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 23 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-19.81 Insider Own17.31% Shs Outstand6.51M Perf Week-11.03%
Market Cap2.07M Forward P/E- EPS next Y-0.97 Insider Trans0.45% Shs Float5.38M Perf Month-30.95%
Income-24.83M PEG- EPS next Q-0.61 Inst Own3.55% Short Float4.27% Perf Quarter-65.55%
Sales0.00M P/S- EPS this Y91.53% Inst Trans117.27% Short Ratio0.75 Perf Half Y-73.75%
Book/sh1.45 P/B0.22 EPS next Y81.59% ROA-59.01% Short Interest0.23M Perf Year-97.46%
Cash/sh1.13 P/C0.28 EPS next 5Y- ROE-199.40% 52W Range0.28 - 18.48 Perf YTD-55.83%
Dividend Est.- P/FCF- EPS past 5Y55.63% ROI-104.61% 52W High-98.28% Beta0.58
Dividend TTM- Quick Ratio2.40 Sales past 5Y-47.23% Gross Margin- 52W Low12.63% ATR (14)0.04
Dividend Ex-Date- Current Ratio2.40 EPS Y/Y TTM73.13% Oper. Margin0.00% RSI (14)23.48 Volatility9.75% 10.36%
Employees20 Debt/Eq2.29 Sales Y/Y TTM- Profit Margin- Recom3.00 Target Price1.00
Option/ShortNo / Yes LT Debt/Eq2.17 EPS Q/Q86.80% Payout- Rel Volume0.21 Prev Close0.32
Sales Surprise- EPS Surprise- Sales Q/Q- EarningsNov 09 AMC Avg Volume305.96K Price0.32
SMA20-16.71% SMA50-41.36% SMA200-69.99% Trades Volume65,025 Change0.35%
Date Action Analyst Rating Change Price Target Change
Jun-26-20Initiated Ladenburg Thalmann Buy $12.25
Feb-01-24 08:00AM
Jan-31-24 08:00AM
Jan-26-24 09:20AM
Jan-25-24 08:30AM
Jan-18-24 09:00AM
08:00AM Loading…
Jan-17-24 08:00AM
Jan-02-24 04:05PM
Dec-19-23 09:30AM
Dec-18-23 08:00AM
Nov-16-23 08:00AM
Nov-14-23 08:55AM
Nov-09-23 04:15PM
Nov-08-23 08:00AM
Oct-12-23 07:30AM
Oct-10-23 07:30AM
08:00AM Loading…
Oct-03-23 08:00AM
Sep-21-23 09:35AM
Aug-25-23 07:20AM
Aug-23-23 08:00AM
Aug-16-23 09:00AM
Aug-07-23 04:05PM
Jul-25-23 09:25AM
Jul-18-23 09:00AM
Jul-14-23 09:00AM
Jun-27-23 08:00AM
Jun-12-23 08:00AM
Jun-05-23 08:00AM
May-15-23 04:30PM
May-11-23 12:20PM
Apr-27-23 08:00AM
04:01PM Loading…
Apr-24-23 04:01PM
Apr-20-23 08:30AM
Apr-17-23 08:00AM
Apr-03-23 07:35AM
Mar-13-23 08:00AM
Mar-06-23 08:00AM
Feb-28-23 08:00AM
Feb-27-23 08:00AM
Feb-24-23 08:00AM
Feb-23-23 12:00PM
Jan-20-23 08:37AM
Dec-05-22 07:30AM
Nov-18-22 12:00PM
Nov-14-22 07:30AM
Oct-25-22 08:00AM
Oct-06-22 06:50AM
Sep-29-22 07:45AM
Sep-28-22 04:05PM
Sep-26-22 08:00AM
Sep-21-22 04:05PM
Sep-06-22 04:05PM
Aug-24-22 02:59PM
Aug-23-22 08:00AM
Aug-11-22 04:05PM
Jun-29-22 08:00AM
May-23-22 10:12AM
May-16-22 07:00AM
May-05-22 04:05PM
Apr-20-22 04:05PM
Mar-31-22 04:05PM
Mar-22-22 01:47PM
Mar-15-22 12:06PM
Mar-10-22 08:00AM
Feb-01-22 02:36PM
Dec-15-21 08:00AM
Nov-22-21 04:59PM
Nov-10-21 04:05PM
Oct-26-21 10:33AM
Oct-25-21 07:30AM
Oct-20-21 07:36AM
Oct-14-21 07:30AM
Oct-12-21 07:30AM
Sep-30-21 02:25PM
Sep-16-21 07:30AM
Aug-05-21 04:01PM
Aug-02-21 08:00AM
Jul-08-21 11:20AM
Jul-07-21 07:30AM
Jul-01-21 07:30AM
Jun-23-21 09:35AM
Jun-09-21 06:40AM
May-13-21 07:30AM
Apr-19-21 07:00AM
Apr-09-21 02:16PM
Mar-30-21 10:13AM
Mar-29-21 05:10PM
Mar-25-21 04:15PM
Mar-23-21 08:30AM
Mar-22-21 04:05PM
Mar-15-21 07:00AM
Windtree Therapeutics, Inc. is a clinical-stage biopharmaceutical and medical device company engaged in the development of novel therapeutics intended to address significant unmet medical needs in important acute care markets. It focuses on the treatment of acute cardiovascular and acute pulmonary diseases. The company was founded by Evan Myrianthopoulos and James S. Kuo on November 6, 1992 and is headquartered in Warrington, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Fraser CraigPresident and CEOSep 27Buy1.022,5002,55057,877Sep 28 07:24 AM
Fraser CraigPresident and CEOSep 26Buy0.902,5002,25055,377Sep 27 07:34 AM
Fraser CraigPresident and CEOApr 26Buy1.771,4972,6507,010Apr 27 07:41 AM
Fraser CraigPresident and CEOApr 25Buy1.891,3152,4855,513Apr 26 07:21 AM